{[5-(4-Fluorophenyl)isoxazol-3-yl]methyl}amine hydrochloride, 95.0%, 100mg

5-Iodo-m-xylene, 99.0%, 25g

(R)-1-[3-(Trifluoromethyl)phenyl]ethylaminehydrochloride, 95.0%, 10g

6-Chloro-1-methyl-3,4-dihydroquinoxalin-2(1H)-one, 95.0%, 5g

2,3,4-Trimethyl-3-pentanol>98.0%(GC)25g

(2-Nitro-5-(trifluoromethyl)phenyl)methanol, 95.0%, 250mg

2-Fluoro-6-iodoaniline, 95.0%, 10g

3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one, 95.0%, 100g

(E)-3-(4-CHLOROPHENYL)-N-(3-METHOXYPHENYL)ACRYLAMIDE, 95.0%, 10mg

3'-Fluoro-2'-hydroxyacetophenone, 98.0%, 5g

4-((2-AMINOETHYL)AMINO)-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE, 95%, 500mg

Myristic acid, min. 98%, for biochemistry, 100 g, plastic packaging.

Lithium formate, 98.0%, 100g